Cellular communication in the developing embryo is mediated by receptor-ligand interactions at the cell surface. Receptor protein tyrosine kinases (RTKs) have been shown to play a critical role in the development of the vertebrate embryo. The eph receptors are a large subclass of RTKs for which a corresponding ligand family has only recently been described. The restricted expression patterns of several eph receptors imply roles for these molecules in early vertebrate development. We have isolated both a ligand of the eph ligand family (ELF), that we have named XELF-a, and an eph-related receptor, XE10, the likely homolog of the murine eck/Sek-2 receptor. At least two forms of the XELF-a transcript are present in the developing embryo. A truncated form of the XELF-a ligand, XELF-a', is the first ELF ligand isolated that lacks both the membrane-spanning and membrane-anchoring motifs conserved among this family, suggesting that ELF ligands can function as fully soluble molecules in vivo. XELF-a and XElO are expressed maternally and throughout early embryogenesis, while XELF-a' is only expressed zygotically. The dynamic expression patterns of these signalling molecules, in both mesoderm and neurectoderm, suggest that they may play a role in the patterning of the early vertebrate embryo.
Introduction
Cell-cell interactions in the developing vertebrate embryo are required for the correct establishment of developmental fates. Receptor protein tyrosine kinases (RTKs) have been shown to mediate signal transduction in the developing embryo in several model systems. For example, in vertebrate embryos, there is strong evidence that the Fibroblast Growth Factor (FGF) receptor is required during early development.
Xenopus embryos injected with a mutant receptor are defective in mesodermal patterning and lack posterior structures (Amaya et al., 1991) . Mice deficient for the FGF receptor-l (fgfrl) also show defects in axial patterning (Deng et al., 1994; Yamaguchi et al., 1994) . All receptor tyrosine kinases are characterized by an extracellular ligand-binding domain, a hydrophobic transmembrane region, and an intracellular, tyrosine kinase catalytic domain (see Yarden and Ullrich, 1988) . Several RTK subfamilies have been defined based on regions of higher structural or sequential homology. In vertebrates, * Corresponding author. the eph family of tyrosine kinase receptors consists of at least 12 independent genes (reviewed in Tuzi and Gullick, 1994) . Several members of this receptor class have been shown to have restricted patterns of expression in the early vertebrate embryo. For example, the ecWSek-2 receptor is detected in ectodermal cells of the mouse gastrula at the distal tip of the primitive streak (i.e., the node; Becker et al, 1994; Ganju et al, 1994; Ruiz and Robertson, 1994) . During hindbrain development, ecWSek-2 is expressed at the level of rhombomere 4 (r4). Other members of the eph family also exhibit spatially restricted patterns of expression in the developing hindbrain. Sek-I, nuWSek-3, and Sek-4 receptor transcripts have been detected in r3 and 6; nuWSek-3 is also present in r2 and in the midbrain (Nieto et al., 1992; Becker et al., 1994; Henkemeyer et al., 1994) . Expression of the mouse mek4 receptor is confined to cells of the forebrain-midbrain junction and the hindbrain at neural tube stages (Cheng and Flanagan, 1994) . In zebrafish, three receptors, rtkl, rtk2, and rtk3 are also present in a subset of mesodermal and neural cells during gastrulation and neurulation (Xu et al., 1994) . Xenopus elk-like kinase (Xek) is expressed maternally, and throughout the central nervous system (CNS) at tailbud stages (Jones et al., 1995) . G50, a Xenopus e&-related gene, is restricted to a subset of rhombomeres and neural crest cells at late neurula stages (Brandli and Kirschner, 1995) . Finally, a Xenopus homolog of sek-I, PagliacciomSek-Z, is expressed in cells of the marginal zone during gastrulation, and subsequently in a highly restricted pattern in the nervous system (Winning and Sargent, 1994) .
Several related ligands have recently been characterized for the eph family receptors. Members of this ligand family are described collectively as eph ligand family (ELF) proteins. B61, first cloned as an immediate-early response gene to inflammation, is the prototype of the ELF gene family (Holzman et al., 1990; Bartley et al., 1994) . 861 expression has been characterized during late gestation, where it is expressed primarily in non-neural tissues . The expression pattern of another family member, ELF-Z, has been described in the mouse at E8.5: the ligand is present in subsets of both mesodermal and neural cells (Cheng and Flanagan, 1994) . B61, LERK2/ELK-L and EHKIL have all been shown to be present in the midgestion rat brain (Davis et al., 1994) . No information regarding the presence, distribution, or function of these ligands during gastrula or pregastrula stages of vertebrate development has been reported.
Based on binding and phosphorylation studies, it has been demonstrated that B6Z is a ligand for the eck and ehkl receptors (Bartley et al., 1994; Davis et al., 1994) . LERK 2/ELK-L interacts with the elk receptor, while EHK-IL can bind both eck and ehk (Beckmann et al., 1994; Davis et al., 1994) . Finally, ELF-Z binds both the mek4 and sek receptors (Cheng and Flanagan, 1994) . These data suggest that this ligand family may be promiscuous in its affinity for eph class receptors in vivo.
All known ELF proteins are found in a membranebound form; these ligands are either transmembrane proteins or contain a hydrophobic C-terminal tail linked to the membrane via a glycophosphatidyl inositol (GPI) anchor. Some workers have described a requirement for ligand anchoring to induce receptor phosphorylation, and postulate that ELF ligands may function only as membrane-bound factors (Davis et al., 1994) .
We describe the isolation of a novel ligand, XELF-a, that shares significant homology with the mammalian ELF genes. In addition, we have isolated a partial cDNA encoding an eph-related receptor, XEIO, that exhibits a similar pattern of expression to that of mouse eck/Sek-2. These factors exhibit dynamic patterns of expression throughout early Xenopus embryogenesis that suggest roles in both mesodermal and neural patterning. We also describe a truncated form of the XELF-a ligand, called XELF-a', that lacks both a membrane-spanning and membrane-anchoring motif. The isolation of XELF-a' suggests that ELF ligands can also function as fully secreted factors in vivo.
Results

Cloning of a novel member of the ELF ligand family
In order to obtain Xenopus ELF genes, we used a fulllength rat B61 cDNA as a probe to screen a gastrula Xenopus cDNA library. Six identical 1.1 kb clones (collectively called X61D) were isolated that showed significant homology with the mammalian ELF family, including a hydrophobic, N-terminal putative signal sequence, four conserved cysteines, and a C-terminal hydrophobic domain. X61D, however, did not contain an initiator methionine. In an effort to obtain a full-length cDNA, we utilized a polymerase chain reaction (PCR) cloning strategy. One cDNA, isolated from reverse transcribed stage 28 RNA, was similar to X6lD but contained two in-frame methionines upstream of a 26 amino acid putative signal sequence. This clone differs from X61D only in its signal sequence: as mentioned above, the coding region of X61D appears to extend beyond the 5' terminus of the cDNA. The open reading frame (ORF) predicts a mature protein with a molecular weight of about 22 kDa (Fig. IA) . BLAST amino acid sequence comparison demonstrated that this cDNA encodes a novel ligand that shares highest identity (57%, excluding the 5' and 3' hydrophobic domains) with human B6Z (Holzman et al., 1990) (Fig. 1B) . Because this clone represents the first member of this ligand family in Xenopus, and in order to remain consistent with the nomenclature of Cheng and Flanagan (1994) we have given this clone the name Xenopus Eph Ligand Family-a (XELF-a).
A variant of XELF-a was isolated from a tailbud stage head library. This 1.0 kb cDNA is identical to XELF-a over the first 161 amino acids but then diverges for 120 nucleotides, introducing a stop codon almost immediately, and lacks essentially all sequence outside the main conserved region for this family (see Davis et al., 1994) (Fig. lA,B) . We have named this short form of the ligand XELF-a'. The absence of a hydrophobic C-terminus in XELF-a' is striking, particularly in light of reports suggesting that the C-termini of mammalian ELF proteins is required for cognate receptor phosphorylation (Davis et al., 1994) . The ORF of this clone predicts a mature protein with a molecular weight of 14.7 kDa. The divergent region of this cDNA includes consensus intron-exon boundary sequence, suggesting that it may be a splicing variant of X.&Y-a (Padgett et al., 1986 ).
XELF-a and XELF-a' are secreted proteins
The putative signal sequence at the amino-termini of XELF-a and XELF-a' suggests that these proteins are secreted. To test the functionality of this hydrophobic domain, we injected synthetic, capped RNA encoding XELF-a and XELF-a' protein into Xenopus oocytes in the presence of [35S]methionine.
We then analyzed conditioned medium from the injected oocytes for the presence of secreted protein under reducing SDS-PAGE. Fig. 2 shows that XELF-a is a secreted protein of about 28 kDa (lane 1). This is slightly larger than the expected size of the mature protein, perhaps reflecting posttranslational modification.
XELF-a' is a secreted protein of about 15 kDa, in agreement with the expected size of the mature protein (Fig. 2, lane 2) . SDS-PAGE analysis under nonreducing conditions did not shift XELF-a or XELF-a' protein to a higher molecular weight, suggesting that these proteins do not form disulfide-linked oligomers (not shown).
Isolation of Xenopus eph-related receptors
To isolate potential receptors for the XELF-a ligand, we screened a gastrula library with the full-length mouse eck cDNA as a probe. From this screen, we obtained two clones, XE9 and XElO. XElO is a partial cDNA of 1.8 kb, with homology to the extracellular domains of a number of eph receptors. XE9 showed 100% identity to the previously reported Xenopus Pagliaccio, an eph-class receptor with sequence and expression pattern similar to that of mouse sek (Winning and Sargent, 1994 ; data not shown).
As a test for the identity of XEIO, we compared a 170 amino acid segment from the 5' end of XEZO with homologous regions from other known eph class receptors. Amino acid comparison demonstrates that XElO shares highest identity (62%) with human eck (Lindberg and Hunter, 1990) (Fig. lC) , and 59% identity with mouse eck (Ganju et al., 1994; Ruiz and Robertson, 1994) . The eph receptor other than eck with highest identity to XElO is human HEKII, with 44% identity (Fox et al., 1995) . This data demonstrates that XEZO is a member of the eph class of receptors, and suggests that it is the Xenopus homolog of eck. This latter conclusion is strengthened when comparative expression data is considered as well (see below).
Developmental expression of XELF-ala' and XEIO
The temporal patterns of expression of XELF-a/a' and XEZO was determined by reverse transcription followed by PCR (RT-PCR), using RNA from different stages of Xenopus development. Fig. 3A shows that XELF-a and XEIO RNA are expressed maternally and are maintained throughout development. Gene-specific oligos were used to compare the temporal expression of XELF-a and XELF-u'. XELF-a' is only detected after the midblastula transition, and is thus only expressed zygotically. XELFa' is expressed at significantly lower levels, compared with XELF-a, at the stages examined: an additional three PCR cycles were required to achieve comparable signal intensity with XELF-a or XEIO.
To determine the number and size of XELF-a and XEZO RNAs, Northern blot analysis was performed on poly-A+ RNA from tailbud stage embryos. A full-length XELF-a probe hybridized to one transcript of 1.2 kb (Fig.   3B ). XELF-a was isolated by a PCR strategy that amplified only the coding region of the cDNA, so the predicted size of this transcript is not known; however, the size of the XELF-a' cDNA is consistent with the single transcript seen on the Northern blot. It is also possible that the 1.2 kb message seen by Northern blot analysis reflects only the XELF-a transcript, since RT-PCR analysis revealed much lower levels of XELF-a' expression. An XEIO probe hybridized to a 4 kb transcript; a second message of 1 kb was also detected (Fig. 3C) . The larger transcript is similar to that seen for murine eck, the receptor with highest identity with XEZO (Ruiz and Robertson, 1994) . Truncated variants of eph receptors have been reported in the literature (Valenzuela et al., 1995) . The 1 kb band may reflect a truncated XEIO transcript. We did not detect a transcript using a probe specific for the 120 in XELF-a'; this likely reflects both the small probe size available and the rarity of the XELF-a' transcript.
XELF-a' is a cytoplasmic RNA
RT-PCR analysis indicated that XELF-a' is a rare message. It was therefore important to determine whether XELF-a' represents a true mRNA present in the cytoplasm, or is simply a partial cDNA derived from a nuclear, unspliced message. To address this issue, we isolated a cytoplasmic fraction from neurula stage embryos (Fig. 4) . Since unspliced heterogeneous nuclear RNA (hnRNA) is processed prior to its export to the cytoplasm, we reasoned that our cytoplasmic fraction would serve as a good PCR template for processed mRNA (see Darnell, 1983) . Using genomic DNA as template, oligos specific for XELF-a and XELF-a' each detect a single major band, larger than that seen with cDNA as template. This allowed us to assay for cytoplasmic enrichment by preparing cDNAs from cytoplasmic versus whole embryo extracts, with or without DNase I treatment: the cytoplasmic pool should not contain a genomic DNA-derived signal, even in the absence of DNase treatment. EFI-a and muscle actin were used as controls for cDNA levels. As expected, the amplified 'genomic' bands were sensitive to DNase I treatment and were unaffected by the presence of reverse transcriptase (RT), while the 'mRNA' bands required the addition of RT (Fig. 4) . Based on the intensity of the 'genomic' bands, we achieved a >20-fold enrichment of cytoplasm in our preparation (Fig. 4 , top panels; cf. lanes 3 and 7). When normalized for levels of EFI-a and muscle actin, however, the levels of both XELF-a and XELF-a' message appear similar in the cytoplasmic versus whole embryo pools (Fig. 4 , bottom panels; cf. lanes 3 and 7). Thus, unspliced, heteronuclear RNA cannot account for the XELF-a' signal, and XELF-a' appears to be a bona fide mRNA.
Spatial distribution of XELF-a, XELF-a', and XElO in Xenopus embryos
Since both XELF-a and XElO are expressed maternally in Xenopus, we wanted to investigate their localization within the oocyte. To this end, we isolated RNA from the animal or vegetal poles of stage 6 oocytes, and repeated the RT-PCR reaction on both pools (Fig. 5) . Vgl, expressed primarily in the vegetal pole of the oocyte, was used as a dissection control (Weeks and Melton, 1985) . No consistent difference in the levels of XELF-a and XElO RNAs were detected in either animal or vegetal regions of the oocyte.
Whole-mount in situ hybridization was used to study the expression of XELF-a and XEIO at several stages of Xenopus development. We were not able to generate an adequate antisense probe with the 120 nucleotide region specific to XELF-a'. However, we performed RT-PCR on microdissections of embryos from gastrula through late neurula stage embryos, using primers specific to both XELF-a and XELF-a'. We found that XELF-a' was present in all regions of the embryo that expressed XELF-a (not shown). XELF-a in situ hybridization data described below thus likely reflects XELF-a' expression, as well.
The expression pattern of XELF-a is shown in Fig. 6 . At blastula and gastrula stages, in situ hybridization and RT-PCR analysis revealed that XELF-a is expressed uniformly throughout the embryo (not shown). At early neu- . XELF-a' RNA is present in the cytoplasm. Cytoplasmic and whole cell extracts were collected from tailbud stage embryos. Each pool was divided into four samples, to which DNaseI and RT were (+) or were not (-) added. Each sample served as template for PCR reactions using primers specific to EFl-a, muscle actin, XELF-a, or X&V-a'. EFl-a and muscle aclin, used as controls for cDNA levels, were at comparable levels in the cytoplasmic versus whole embryo samples (bottom left panel; cf. lanes 1 and 5, 3 and 7). Both XELF-a and XELF-a' primers generate distinct bands using genomic DNA (lane 9) versus cDNA as template. No genomic band was seen in the -DNaseI cytoplasmic fraction with either of these primer sets, indicating that nuclei were largely eliminated from this pool (top panels, middle and right; cf. lanes 3 and 7). When normalized for levels of EFIa and musde actin, however, the levels of both XELF-a and XELF-a' cDNA-specific signal appear similar in the cytoplamic versus whole embryo pools (bottom panels, middle and right; cf. lanes 3 and 7). ral plate stages (stage 14), XELF-a RNA is expressed in both axial mesoderm and neurectoderm (Fig. 6A) . The expression in the notochord is uniform along the anteroposterior (A-P) axis, while in the neurectoderm, XELF-a is expressed as two stripes in the anterior portion of the neural plate (arrows, Fig. 6A ). The more anterior of the two bands coincides with the presumptive forebrain, at the rostra1 edge of the neural plate. The more posterior 1 Animal 1 Vegetal Stage 6 Oocyte stripe coincides with the region of the hindbrain. Transverse sections through these embryos revealed that the expression in the neural plate is limited to the sensorial layer of the neurectoderm (not shown). To determine exactly the A-P boundary of the more posterior band, we compared the expression pattern of XELF-a with that of Engruiled-2 (En-2), which stains the midbrain-hindbrain boundary (Hemmati-Brivanlou et al., 1989) (Fig. 6B) . Fig. 5 . Localization of XELF-a and XElO in oocytes. Stage 5 and 6 oocytes were dissected along the animal-vegetal axis into animal, equatorial and vegetal thirds (left panel). The equatorial third was discarded, and RT-PCR was performed on ten animal and ten vegetal poles. Vg-1 expression was used as a dissection control. EFI-a was used as a loading control. The -RT lane contains all reagents except RT and was used as a negative control. Anterior is to the right; dorsal is at top. Transcript is abundant in the eyes (arrowhead), throughout the anterior spinal cord, in caudal, undifferentiated mesoderm (large arrow) and in anterior somites (e.g., small arrow). (G) Lateral view of XELF-a/a' expression at tailbud stage. Anterior is to the right; dorsal is at top. Strong expression is maintained in the eye (arrow) at this stage. Weak expression is detected throughout the craniofacial structures.
Embryos in (F,G) were cleared in 2:1 BB:BA.
Double hybridizations
with XELF-a and En-2 showed a colocalization of En-2 and the posterior XELF-a band, placing the caudal XELF-a stripe at the level of the midbrain-hindbrain (Fig. 6C) . Krox-20 is specifically expressed in presumptive rhombomere 3 at early neural plate stages (Bradley et al., 1992) (Fig. 6D) . Double hybridizations with both XELF-a and Krox-20 demonstrated that the posterior XELF-a stripe is clearly anterior to the Krox-20 stain, and confirms the localization of XELF-a to the approximate midbrain-hindbrain boundary (Fig. 6E) . By late neurula stages, transcript is abundant in the eyes and throughout the anterior spinal cord (Fig. 6F) . We also detect expression in caudal, undifferentiated mesoderm and in anterior somites (Fig. 6F and data not shown) . By tadpole stages, XELF-a expression is maintained in the head, including the eye, and diffusely throughout the craniofacial structures (Fig. 6G and data not shown) .
XEIO expression was first detected by whole-mount in situ hybridization in early gastrulae (stage 10.5). Fig. 7A shows that while the transcript is enriched in the dorsal lip (arrow), message can be detected throughout the animal pole and marginal zone. By late gastrula stages, XEZO transcript is abundant around the blastopore (Fig. 7B-D) . This high level of posterior expression persists through to tailbud stages (Fig. 7E-I ). In the late gastrula (stage 12), XElO RNA can be detected in both the notochord and the differentiating neurectoderm (Fig. 7C) . Interestingly, the expression of this receptor in the notochord is graded with strongest expression caudally (Fig. 7C,D) . Transverse sections indicate that XEZO is also expressed in the midline of the neural plate, the notoplate, overlying the region of expression in the posterior notochord; faint expression was also detected in the paraxial mesoderm (not shown). Two stripes of expression are apparent along the A-P axis Fig. 7B,E) in the neural plate. The more anterior stripe (Fig. 7E, small arrow) corresponds to the anterior edge of the neural plate, while the posterior stripe (large arrow) coincides with the presumptive hindbrain. This posterior expression begins as two independent domains on each side of the dorsal midline, which subsequently fuse at the midline following the convergence of the neural plate (Fig. 7B) . To precisely map the location of the caudal stripe within the hindbrain, Knox-20, which labels both rhombomeres 3 and 5 following neural tube closure (Bradley et al., 1992) , was used as a comparative marker. In situ hybridization performed with both Krox-20 and XElO resulted in the labelling of three adjacent rhombomeres, indicating that XEIO is expressed specifically in rhombomere 4 (Fig. 8A-C) .
Neural crest cells in line with rhombomere 4 also express XElO ( Fig. 7F ). These cells eventually odcupy the second branchial arch (Fig. 7H , and data not shown). At late neurula stages (stage 20), while the hindbrain expression is maintained, forebrain expression becomes gradually restricted to the developing eye buds (Fig. 7F-I) . Finally, at tailbud stages, anterior cells of the otic vesicle also express XEZO (Fig. 71) .
Discussion
In this study we report the isolation and characterization of two variants of an ELF ligand, XELF-a, and an eph class receptor, XEIO, during early Xenopus development. The closest known relative of XELF-a is the human B61 (hB61) gene (Holzman et al., 1990) . The early expression pattern of hB61 is not known, but murine B61 expression is quite distinct from that of XELF-a: transcripts are restricted to endothelial cells duriiig early development (J.R., unpublished observations). Given this comparative expression data, and the relatively low sequence identity between XELF-a and hB61, XELF-a may represent a novel ELF gene. There are at least two forms of the XELF-a ligand: XELF-a' includes a 120 nucleotide insertion in the coding region of XELF-a, introducing a stop codon almost immediately. XELF-a' is functionally thus a C-terminal truncation of XELF-a, which eliminates -50 amino acids, including a hydrophobic, C-terminal stretch. The isolation of a clone that extends 5' of the putative XELF-a initiating methionine, X61D, implies that there might be a third, longer form of the transcript.
All known ELF ligands contain either a hydrophobic, internal transmembrane domain or a hydrophobic Cterminus, involved in GPI-mediated membrane anchoring. It has been speculated that these ligands are presented to their receptors by cell surface contact (Beckmann et al., 1994; Cheng and Flanagan, 1994; Davis et al., 1994; Shao et al., 1995) . One group has reported that mutant, soluble ELF ligands were incapable of phosphorylating their cognate receptors unless clustered by antibodymediated aggregation (Davis et al., 1994) . Wild-type, membrane-bound ligands were capable of receptor phosphorylation. XELF-a' is the first ELF ligand reported to contain neither a transmembrane domain nor a C-terminal hydrophobic domain, suggesting that these factors exist as fully soluble molecules in vivo. We indeed find that the truncated XELF-a' is secreted when produced by oocytes. We also find, somewhat surprisingly, that XELF-a is detected in soluble form, implying that there is an activity, present in the oocyte, that can cleave a putative membrane-associated form of the ligand. A precedent for the presence of soluble ELF ligands comes from the initial description of the cloning and characterization of B61, the prototype for the ELF ligand family (Holzman et al., 1990 ). These workers report that an antibody to B61 immunoprecipitated a tumor necrosis factor-a inducible protein from endothelial cell conditioned medium; in these cells, no membrane-bound B61 was detected. Under some conditions, then, soluble ELF ligands are produced by cells. One intriguing possibility is that the truncated ELF ligands interfere with eph signalling, either by direct interaction with membrane-associated ligands, or indirectly, by competition for receptor sites. Interaction between the two XELF-a proteins has not yet been assayed, although XELF-a and XELF-a' do not appear to form disulphide-linked homodimers. We also report the isolation of an eph-class receptor, XE10, that bears significant homology to the mammalian eck/Sek-2 receptor. XElO is expressed maternally and is enriched in the region of the blastopore, including the dorsal lip, at gastrula stages. This dorsal expression is reminiscent of data published for murine eckbek-2, which is found in the cells of the definitive node (Becker et al., 1994; Ganju et al., 1994; Ruiz and Robertson, 1994) . During neural plate stages, the expression of XEZO includes a stripe that coincides with presumptive rhombomere 4, and a more anterior stripe at the level of the forebrain. The hindbrain localization of XEIO also resembles that of murine ecWSek-2 (Becker et al., 1994; Ganju et al., 1994; Ruiz and Robertson, 1994) . Forebrain expression, however, has not been detected in the mouse. XEIO expression is graded in the notochord and notoplate at early neural plate stage embryos, with strongest expression caudally. If XELF-a acts as a ligand for XEIO in the dorsal midline, it is tempting to speculate that, since the ligand is uniformly expressed along the notochord, the expression of the XElO receptor provides a graded signal with the highest levels at the posterior pole of the embryo. eck protein has been described in a differential rostrocauda1 distribution similar to that reported here (Ganju et al., 1994) . Thus, when comparative expression data are considered along with sequence homology, XEIO seems likely to be the Xenupus eck homolog.
The Xenupus eph-class receptor, Pagliaccio, has previously been described (Winning and Sargent, 1994) . XELF-a, XEIO, and Pagliaccio are all expressed in the presumptive forebrain, which suggests that XELF-a may interact with one or both of the receptors in this domain (Winning and Sargent, 1994 , and not shown). There are also, however, regions of non-overlapping expression. For example, in the neural plate, while both receptors are expressed in the hindbrain posterior to rhombomere 2, the most posterior region of ligand expression is the midbrain-hindbrain boundary. Given the biochemical data suggesting that some members of this ligand family can bind to several members of the eph receptor family (Davis et al., 1994) , the possibility exists that XELF-a is signalling to multiple receptors during early Xenopus embryogenesis, some of which have not yet been characterized. At tailbud stages, the Xek receptor is expressed throughout the CNS (Jones et al., 1995) . While the early expression of Xek has yet to be described in detail, XELF-a may interact with Xek at earlier stages in the rostra1 neurectoderm.
Xek is expressed at low levels at mid-neurula stages, but appears to be enhanced in dorsoanterior regions (Jones et al., 1995) . It is also likely that other XELF proteins are present in the early embryo, and are communicating through XEIO, Xek, and/or Pagliaccio.
The expression pattern of G50, a potential Xenoprrs homolog of eck/Sek-2 has been described at late neurula stages, and resembles that reported here for XEIO: both transcripts are expressed in the caudal tip of the embryo, and in subsets of neural crest cells and the developing hindbrain (Brandli and Kirschner, 1995) . G50 expression, however, is reported in presumptive rhombomere 3; we detect XElO in presumptive rhombomere 4. AS both clones are partial cDNAs, we were unable to make a direct sequence comparison between XEIO and G50. It is possible that XEIO and G50 are two, related genes with differential expression in the hindbrain. G50 may thus represent an additional target for XELF ligands in the anterior neural plate/neural tube.
The eph signalling family of ligands and receptors have been associated with multiple biological functions, including axonal pathfinding and fasciculation (see reviews: Barinaga, 1995; Tessier-Lavigne, 1995) and angiogenesis . These molecules may also function early in development, as several eph receptors are present in the gastrula or pregastrula embryo (Winning and Sargent, 1994; Xu et al., 1994; and this study) . Our work provides the first evidence for ELF ligand expression in the pregastrula embryo, and also describes the subsequent localization of both the XELF-a/a' ligands and the XEIO receptor in the axial mesoderm. These expression patterns further imply a role for eph signalling in the induction and/or patterning of mesoderm in the early embryo.
Numerous eph receptors are expressed in the developing anterior neural plate and neural tube. From this work, we can add the XEZO receptor to this rapidly growing list. In addition, we report that the XELF-a ligand is also expressed in both the prospective forebrain and at the approximate midbrain-hindbrain boundary. Much speculation has surrounded the possible roles of eph signalling in the patterning of the developing vertebrate brain. A recent report has provided the first functional evidence for patterning of the anterior CNS by eph signalling molecules. Xu et al. (1995) assayed the effects of truncated, dominant negative Paliaccio/XSek-1 receptors injected into Xenopus and zebrafish embryos. PagliaccioKSek-I, and its zebrafish homolog rtkl, is normally expressed in rhombomeres 3 and 5 (r3 and r5). Embryos expressing the truncated receptors displayed misexpression of r3/r5 molecular markers in adjacent, even-numbered rhombomeres. This result indicates that PagZiaccioKSek-1 is essential for the tight regulation of patterning in a subset of rhombomeres in the developing hindbrain. The localization of other eph ligands and receptors, including XEIO and XELF-a/a', to discrete regions of the rostra1 neurectoderm suggests that the combinatorial communication of these molecules may play a role in patterning throughout the developing vertebrate brain.
Experimental procedures
Isolation of eph ligands and receptors cDNAs
Plaques (106) of a stage 11 LgtlO Xenopus cDNA library (D.A. Melton, Harvard University; staging after Nieuwkoop and Faber, 1967) were screened at moderate stringency (40°C) using either a rat B61 cDNA nucleotides l-1116) , or a mouse eck cDNA (Ruiz and Robertson, 1994 ; nucleotides l-3300) as probe. Two clones, XE9 and XEIO, were isolated using mouse eck as a probe. Six identical clones (X61D) were isolated using B61 cDNA as a probe.
vg-1: U:S'-GACCATATGTGCCAGTAC D:5'-CCA'ITGCTTAATCCAAGC All reactions were performed for 27 cycles except for EFI-a and muscle actin, which were performed for 23 cycles, and XELF-a', which were performed for 30 cycles.
X61D did not contain an initiating methionine; PCR was used to isolate full-length clones. XELF-a' was amplified by PCR using a stage 28 head LZapII Xenopus cDNA library (Hemmati-Brivanlou et al., 1991) . The primers used were: 5'-AATAACCCTCACTAAAGGG AAC, derived from the Zap polylinker, and 5'-GGA GATCTCTTAGATGTTGGCACCACC, derived from the 3' end of X61D. DNA was denatured at 94'C, annealed at 57'C, and extended at 72'C, each for 1 min. This cycle was repeated 30 times.
Preparation of cytoplasmic RNA
To generate XELF-a, 6,ug of RNA from stage 28 Xenopus embryos was used to generate first strand cDNA. The primers used were: 5'-GGAGATCTGGAATGATGG AGTTG, derived from the 5' end of clone XELF-a', and 5'-GGAGGCCTGCCTGCCCAGGTGAGCAG, derived from a region downstream of the putative stop codon of X61D. DNA was denatured at 94°C for 1 min, annealed at 55°C for 1 min, and extended at 72'C for 2 min. This cycle was repeated 35 times.
Twenty-five embryos were harvested at stage 25-28, homogenized with ten strokes of a glass (B-type) pestle in 5 ~01s. of extraction buffer (10 mM Tris, pH 7.5; 70 mM KCl; 7 mM MgCl,; 0.1 mM EDTA; 2.5 mM D'IT; modified from Murray, 1991) , with 0.25% Triton X-100 and centrifuged 2 X 10 min at 650 X g and 4°C. The nuclear pellet was discarded after each spin. Proteinase K treatment, DNase treatment, and RT-PCR were performed as described above and in Wilson and Melton (1994) . Two whole embryos or 300 ng genomic DNA were used as controls. Bands representing genomic DNA were exposed overnight at -7O"C; bands representing mRNA were exposed for 2 days at -70°C.
RNA preparation, microinjection, and oocyte dissection
All cDNAs were subcloned into pBluescript II KS (+), and sequenced by the dideoxy-chain termination method (Sanger et al., 1977) . Sequence analysis was carried out using the DNA Strider software package and the NIH BLAST program.
Northern blot analysis
PolyA+ RNA (4pg) from stage 28 embryos was electrophoresed on formaldehyde agarose gels and blotted on GeneScreen membranes (NEN). Blots were crosslinked on a Stratalinker, hybridized at 42'C to radiolabelled XELF-a or XElO probes, and exposed for 2 days at -70°C. mRNA was synthesized in vitro in the presence of cap analog using the mMessage mMachine kit (Ambion). The protein coding regions of XELF-a and XELF-a' were subcloned into p64TS (P. Wilson, unpublished data), a modified version of pSP64T (Krieg and Melton, 1984) . Both constructs were linearized with BamHI; RNA was synthesized using the Sp6 promoter. Follistatin RNA was generated as described previously .
For oocyte translation, 30 ng of RNA was injected into the vegetal pole of stage 5 and 6 oocytes. Oocytes were cultured, and protein was harvested and analyzed as described previously .
RT-PCR
RT-PCR was performed as described in Wilson and Melton (1994) with one variation: 100 @reaction random hexamers replaced oligo-dT for reverse transcription. Primers for EFl-a and muscle actin are as described in HemmatiBrivanlou et al., 1994 . Additional primers used for this study are as follows: XELF-a: U:S-CCTCCTGTTAACGTTCAC For oocyte dissections, stage 5 and 6 oocytes were placed on dry ice covered with a kimwipe. Embryos were dissected into animal and vegetal poles, with the equatorial third of the oocyte discarded. Ten pieces were used to generate each first strand cDNA.
Whole-mount in situ hybridization
D:S'-GGAGGCCTGCCTGCCCAGGTGAGCAG
Whole-mount in situ hybridization was performed as described in Harland, 1991. BM purple AP substrate (Boehringer Mannheim) replaced BCIP/NBT. Some embryos were cleared in 2:l benzyl benzoate/benzyl alcohol (BB:BA). Antisense probes were generated in the pres-ence of rUTP-digoxygenin (Boerhinger Mannheim Biochemicals) as shown in Table 1 .
